Samsung and Massachusetts General Hospital Launch Joint Study To Investigate GLP-1 Treatment Monitoring With Galaxy Watch

May 28, 2026

Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly announced a research study to investigate the efficacy of Galaxy Watch in assisting adults starting GLP-1RA1 therapy to monitor and potentially manage muscle loss. With nearly one in five adults in the US saying they have taken GLP-1 medication, this innovative clinical study will investigate how continuous data from Galaxy Watch can help patients and clinicians monitor and mitigate muscle loss by providing a clearer, more holistic view of a person’s body composition and activity levels during treatment.

For more information, please see:
https://news.samsung.com/global/samsung-and-massachusetts-general-hospital-launch-joint-study-to-investigate-glp-1-treatment-monitoring-with-galaxy-watch